Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma

Published:2019-12 Issue:6 Volume:29 Page:636-640
ISSN:1167-1122
Container-title:European Journal of Dermatology
language:
Short-container-title:

Author:

Lavaud Justine,Blom Astrid,Longvert Christine,Fort Magali,Funck-Brentano Elisa,Saiag Philippe

Publisher

John Libbey Eurotext

Subject

Dermatology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful treatment of trichilemmal carcinoma with distant metastasis using pembrolizumab: a case report and review;Immunotherapy;2024-05-23

2. Metastatic patterns and treatment options for head and neck cutaneous squamous cell carcinoma (Review);Molecular and Clinical Oncology;2024-04-24

3. Immunotherapy and Hypofractionated Radiotherapy in Older Patients with Locally Advanced Cutaneous Squamous-Cell Carcinoma of the Head and Neck: A Proposed Paradigm by the International Geriatric Radiotherapy Group;Cancers;2023-10-13

4. Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre;Cancers;2023-08-29

5. Leptomeningeal carcinomatosis from a recurrent cutaneous squamous cell carcinoma with perineural invasion in a lung transplant patient;JAAD Case Reports;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP